GlassScriptPhysician profile
Jackie Lynn Snell
NPI 1114229366
$2,321.04
in general payments reported to CMS, 2019-2025
18 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.10 · 2022: $731 · 2023: $953 · 2024: $373 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,553.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $724.46 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $251.90 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $217.55 | 2022-2024 | Vraylar, Ubrelvy, Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $216.38 | 2021-2024 | |
| Pfizer INC. | $202.26 | 2022-2024 | |
| Lilly USA, LLC | $173.04 | 2022-2025 | Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.91 | 2022-2024 | Xifaxan, Trulance |
| Amgen INC. | $87.65 | 2024-2025 | Repatha, Repatha |
| Exact Sciences Corporation | $83.17 | 2023-2025 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $52.09 | 2022-2023 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $43.25 | 2023-2025 | Trintellix |
| Idorsia Pharmaceuticals US INC | $42.53 | 2022-2024 | Quviviq |
| Lundbeck LLC | $33.72 | 2023 | Vyepti |
| Abbott Laboratories | $22.32 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $21.76 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $19.97 | 2022 | |
| Ethicon US, LLC | $14.14 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackie Snell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.